CXCL10 and cutaneous mastocytosis: In addition, studies revealed that circulating levels of CXCL10 is the most accurate predictor of CM mortality (69) (70) and its neutralization with specific mAbs, significantly prevents brain intravascular inflammation and protects infected animals from CM by reducing peripheral parasitemia level (71–73).